JP2005521383A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005521383A5 JP2005521383A5 JP2003545688A JP2003545688A JP2005521383A5 JP 2005521383 A5 JP2005521383 A5 JP 2005521383A5 JP 2003545688 A JP2003545688 A JP 2003545688A JP 2003545688 A JP2003545688 A JP 2003545688A JP 2005521383 A5 JP2005521383 A5 JP 2005521383A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- peptide
- peptide represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 43
- 239000008194 pharmaceutical composition Substances 0.000 claims 23
- 210000003491 Skin Anatomy 0.000 claims 13
- 210000002784 Stomach Anatomy 0.000 claims 8
- 210000001519 tissues Anatomy 0.000 claims 8
- 102000004965 antibodies Human genes 0.000 claims 6
- 108090001123 antibodies Proteins 0.000 claims 6
- 201000010099 disease Diseases 0.000 claims 6
- 210000000481 Breast Anatomy 0.000 claims 5
- 210000002808 Connective Tissue Anatomy 0.000 claims 5
- 210000001508 Eye Anatomy 0.000 claims 5
- 210000000214 Mouth Anatomy 0.000 claims 5
- 210000003205 Muscles Anatomy 0.000 claims 5
- 210000001331 Nose Anatomy 0.000 claims 5
- 210000002741 Palatine Tonsil Anatomy 0.000 claims 5
- 210000003800 Pharynx Anatomy 0.000 claims 5
- 210000002307 Prostate Anatomy 0.000 claims 5
- 210000000056 organs Anatomy 0.000 claims 5
- 210000004100 Adrenal Glands Anatomy 0.000 claims 4
- 210000004369 Blood Anatomy 0.000 claims 4
- 210000000988 Bone and Bones Anatomy 0.000 claims 4
- 210000004556 Brain Anatomy 0.000 claims 4
- 210000001072 Colon Anatomy 0.000 claims 4
- 210000003238 Esophagus Anatomy 0.000 claims 4
- 210000000232 Gallbladder Anatomy 0.000 claims 4
- 210000002216 Heart Anatomy 0.000 claims 4
- 210000000936 Intestines Anatomy 0.000 claims 4
- 210000003734 Kidney Anatomy 0.000 claims 4
- 210000004185 Liver Anatomy 0.000 claims 4
- 210000004072 Lung Anatomy 0.000 claims 4
- 210000001165 Lymph Nodes Anatomy 0.000 claims 4
- 210000004324 Lymphatic System Anatomy 0.000 claims 4
- 210000001672 Ovary Anatomy 0.000 claims 4
- 210000000496 Pancreas Anatomy 0.000 claims 4
- 210000002990 Parathyroid Glands Anatomy 0.000 claims 4
- 210000003635 Pituitary Gland Anatomy 0.000 claims 4
- 210000000664 Rectum Anatomy 0.000 claims 4
- 210000003079 Salivary Glands Anatomy 0.000 claims 4
- 210000000278 Spinal Cord Anatomy 0.000 claims 4
- 210000000952 Spleen Anatomy 0.000 claims 4
- 210000001550 Testis Anatomy 0.000 claims 4
- 210000001685 Thyroid Gland Anatomy 0.000 claims 4
- 210000003932 Urinary Bladder Anatomy 0.000 claims 4
- 210000004291 Uterus Anatomy 0.000 claims 4
- 239000008280 blood Substances 0.000 claims 4
- 230000001850 reproductive Effects 0.000 claims 4
- 210000004027 cells Anatomy 0.000 claims 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims 3
- 210000001367 Arteries Anatomy 0.000 claims 2
- 206010003210 Arteriosclerosis Diseases 0.000 claims 2
- 206010015037 Epilepsy Diseases 0.000 claims 2
- 206010020718 Hyperplasia Diseases 0.000 claims 2
- 206010020880 Hypertrophy Diseases 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 230000036244 malformation Effects 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 150000007523 nucleic acids Chemical class 0.000 claims 2
- 200000000009 stenosis Diseases 0.000 claims 2
- 230000036262 stenosis Effects 0.000 claims 2
- 238000002054 transplantation Methods 0.000 claims 2
- 201000011528 vascular disease Diseases 0.000 claims 2
- 206010002022 Amyloidosis Diseases 0.000 claims 1
- 206010003816 Autoimmune disease Diseases 0.000 claims 1
- 206010010356 Congenital anomaly Diseases 0.000 claims 1
- 206010012335 Dependence Diseases 0.000 claims 1
- 208000005679 Eczema Diseases 0.000 claims 1
- 206010014698 Endocrine disease Diseases 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 206010016654 Fibrosis Diseases 0.000 claims 1
- 210000004209 Hair Anatomy 0.000 claims 1
- 206010061205 Hereditary disease Diseases 0.000 claims 1
- 206010022114 Injury Diseases 0.000 claims 1
- 210000003563 Lymphoid Tissue Anatomy 0.000 claims 1
- 208000002720 Malnutrition Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 208000008466 Metabolic Disease Diseases 0.000 claims 1
- 208000008425 Protein Deficiency Diseases 0.000 claims 1
- 208000006641 Skin Disease Diseases 0.000 claims 1
- 206010046996 Varicose vein Diseases 0.000 claims 1
- 238000002679 ablation Methods 0.000 claims 1
- 201000001320 atherosclerosis Diseases 0.000 claims 1
- 201000009596 autoimmune hypersensitivity disease Diseases 0.000 claims 1
- 230000001580 bacterial Effects 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 238000002512 chemotherapy Methods 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 230000000875 corresponding Effects 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 claims 1
- 238000000315 cryotherapy Methods 0.000 claims 1
- 201000004624 dermatitis Diseases 0.000 claims 1
- 201000009910 diseases by infectious agent Diseases 0.000 claims 1
- 201000010870 diseases of metabolism Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 231100001003 eczema Toxicity 0.000 claims 1
- 201000001957 endocrine system disease Diseases 0.000 claims 1
- 230000004761 fibrosis Effects 0.000 claims 1
- 238000001415 gene therapy Methods 0.000 claims 1
- 201000002406 genetic disease Diseases 0.000 claims 1
- 238000009169 immunotherapy Methods 0.000 claims 1
- 200000000018 inflammatory disease Diseases 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 238000007913 intrathecal administration Methods 0.000 claims 1
- 230000002601 intratumoral Effects 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 238000002647 laser therapy Methods 0.000 claims 1
- 235000018343 nutrient deficiency Nutrition 0.000 claims 1
- 230000003071 parasitic Effects 0.000 claims 1
- 238000001126 phototherapy Methods 0.000 claims 1
- 201000004681 psoriasis Diseases 0.000 claims 1
- 200000000008 restenosis Diseases 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- 230000000699 topical Effects 0.000 claims 1
- 230000000472 traumatic Effects 0.000 claims 1
- 238000002255 vaccination Methods 0.000 claims 1
- 230000003612 virological Effects 0.000 claims 1
Claims (35)
- a)配列番号8:
b)配列番号9:
c)配列番号10:
d)配列番号11:
e)配列番号12:
f)配列番号13:
g)配列番号14:
h)配列番号15:
i)配列番号16:
j)配列番号17:
k)配列番号18:
l)配列番号19:
m)配列番号20:
n)配列番号21:
o)配列番号22:
p)配列番号23:
q)配列番号24:
r)配列番号25:
s)配列番号26:
t)配列番号27:
u)配列番号28:
v)配列番号29:
w)配列番号30:
x)配列番号31:
y)配列番号32:
z)配列番号33:
aa)配列番号34:
bb)配列番号35:
cc)配列番号36:
dd)配列番号37:
ee)配列番号38:
ff)配列番号39:
gg)配列番号40:
hh)配列番号41:
ii)配列番号42:
jj)配列番号43:
kk)配列番号44:
ll)配列番号45:
mm)配列番号46:
nn)配列番号47:
oo)配列番号48:
からなる群から選ばれる少なくとも1個のNTPペプチドを含むペプチド。 - 請求項1に記載の1個以上のペプチドとその担体とを含む組成物。
- 請求項1に記載のペプチドの相同体、誘導体、フラグメント、又は変異体を含むペプチド。
- 請求項1に記載のペプチドのアミノ酸配列を基にするとリバース−D順の配列のアミノ酸を含むペプチド。
- ペプチドの3’又は5’末端のいずれかにフランキングしている少なくとも1個〜25個までの追加のアミノ酸を有する請求項1に記載のペプチドを含むペプチド。
- 請求項1に記載の少なくとも2個のペプチドを含むペプチド。
- 請求項1に記載のペプチドの少なくとも2回の反復を含むペプチド。
- 請求項1に記載のペプチドのミメティック。
- 抗体、抗体のフラグメント又は抗体様分子に融合した請求項1に記載のペプチドを含むペプチド。
- 請求項1に記載のペプチド並びにその相同体、フラグメント及び変異体に対応するアミノ酸配列をコードする核酸。
- 請求項10に記載の1個以上の核酸とその製薬上許容しうる担体とを含む組成物。
- 細胞の除去又は破壊を必要とする哺乳動物における状態の治療するための医薬組成物であって、請求項1に記載のペプチドを含む、前記医薬組成物。
- 前記ペプチドが、経口、皮下、皮内、鼻腔内、静脈内、筋肉内、くも膜下、鼻腔内、腫瘍内、局所、及び経皮からなる群から選ばれる方法によって投与される、請求項12に記載の医薬組成物。
- 外科的切除、臓器移植、組織移植、化学療法、免疫療法、ワクチン接種、熱又は電気的剥離、寒冷療法、レーザー療法、光線療法、遺伝子療法、及び放射線からなる群から選ばれる治療法による前記哺乳動物の治療の前、中、後に投与される、請求項12に記載の医薬組成物。
- 前記状態が、肺、乳房、胃、膵臓、前立腺、膀胱、骨、卵巣、皮膚、腎臓、洞、結腸、腸、胃、直腸、食道、心臓、脾臓、唾液腺、血液、脳及びその外皮、脊髄及びその外皮、筋肉、結合組織、副腎、副甲状腺、甲状腺、子宮、精巣、脳下垂体、生殖器官、肝臓、胆嚢、眼、耳、鼻、咽頭、扁桃、口、及びリンパ節並びにリンパ系からなる群から選ばれる組織の良性又は悪性腫瘍である、請求項12に記載の医薬組成物。
- 前記状態が、肺、乳房、胃、膵臓、前立腺、膀胱、骨、卵巣、皮膚、腎臓、洞、結腸、腸、胃、直腸、食道、心臓、脾臓、唾液腺、血液、脳及びその外皮、脊髄及びその外皮、筋肉、結合組織、副腎、副甲状腺、甲状腺、子宮、精巣、脳下垂体、生殖器官、肝臓、胆嚢、眼、耳、鼻、咽頭、扁桃、口、及びリンパ節並びにリンパ系からなる群から選ばれる組織の過形成、肥大、又は過成長である、請求項12に記載の医薬組成物。
- 前記状態が、肺、乳房、胃、膵臓、前立腺、膀胱、骨、卵巣、皮膚、腎臓、洞、結腸、腸、胃、直腸、食道、心臓、脾臓、唾液腺、血液、脳及びその外皮、脊髄及びその外皮、筋肉、結合組織、副腎、副甲状腺、甲状腺、子宮、精巣、脳下垂体、生殖器官、肝臓、胆嚢、眼、耳、鼻、咽頭、扁桃、口、及びリンパ節並びにリンパ系からなる群から選ばれる組織のウィルス性、細菌性、又は寄生虫性変化である、請求項12に記載の医薬組成物。
- 前記状態が、肺、乳房、胃、膵臓、前立腺、膀胱、骨、卵巣、皮膚、腎臓、洞、結腸、腸、胃、直腸、食道、心臓、脾臓、唾液腺、血液、脳及びその外皮、脊髄及びその外皮、筋肉、結合組織、副腎、副甲状腺、甲状腺、子宮、精巣、脳下垂体、生殖器官、肝臓、胆嚢、眼、耳、鼻、咽頭、扁桃、口、及びリンパ節並びにリンパ系からなる群から選ばれる組織の奇形である、請求項12に記載の医薬組成物。
- 前記組織がリンパ組織である、請求項15ないし18のいずれか1項に記載の医薬組成物。
- 前記状態が扁桃肥大である、請求項12に記載の医薬組成物。
- 前記状態が前立腺過形成である、請求項12に記載の医薬組成物。
- 前記状態が乾癬である、請求項12に記載の医薬組成物。
- 前記状態が湿疹である、請求項12に記載の医薬組成物。
- 前記状態が皮膚病である、請求項12に記載の医薬組成物。
- 前記状態が組織に対する美容修正である、請求項12に記載の医薬組成物。
- 前記組織が、皮膚、眼、耳、鼻、咽頭、口、筋肉、結合組織、毛髪、及び乳房である、請求項15ないし18のいずれか1項に記載の医薬組成物。
- 前記状態が血管疾患である、請求項12に記載の医薬組成物。
- 前記状態が痔である、請求項12に記載の医薬組成物。
- 前記状態が静脈瘤である、請求項12に記載の医薬組成物。
- 前記血管疾患がアテローム性動脈硬化又は動脈硬化である、請求項27に記載の医薬組成物。
- 前記状態が、炎症性疾患、自己免疫疾患、代謝性疾患、遺伝性疾患/遺伝病、外傷性疾患又は身体外傷、栄養欠乏症、感染症、アミロイド病、線維症、沈着症、先天性奇形、酵素欠乏症、中毒、酩酊、環境病、放射線疾患、内分泌性疾患、消耗性疾患及び機械的疾患からなる群から選ばれる、請求項12に記載の医薬組成物。
- 前記ペプチドが、抗体、抗体フラグメント、及び抗体様結合分子からなる群から選ばれる分子と複合、連結、又は結合しており、前記分子は他の細胞に結合するより腫瘍又は他の標的への結合の方に高い親和性を有している、請求項12に記載の医薬組成物。
- 前記ペプチドが、該ペプチドと、抗体、抗体フラグメント、及び抗体様結合分子からなる群から選ばれる分子とからなる単一の新規クローン組換え分子の一部であり、前記分子は他の細胞に結合するより腫瘍又は他の標的への結合の方に高い親和性を有している、請求項12に記載の医薬組成物。
- 前記状態が、動脈の又は動脈内に設置又は移植されたステントの狭窄、再狭窄、閉塞又は遮断である、請求項12に記載の医薬組成物。
- ステントの狭窄、閉塞又は遮断を防止又は阻害する方法であって、前記ステントを少なくとも治療上有効量の請求項1に記載のペプチドで被覆することを含む方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33147701P | 2001-11-16 | 2001-11-16 | |
US60/331,477 | 2001-11-16 | ||
PCT/CA2002/001757 WO2003044053A2 (en) | 2001-11-16 | 2002-11-18 | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011011764A Division JP5357196B2 (ja) | 2001-11-16 | 2011-01-24 | 細胞の除去又は破壊を必要とする腫瘍及び他の状態の治療に有効なペプチド |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2005521383A JP2005521383A (ja) | 2005-07-21 |
JP2005521383A5 true JP2005521383A5 (ja) | 2006-01-12 |
JP4717349B2 JP4717349B2 (ja) | 2011-07-06 |
Family
ID=23294135
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003545688A Expired - Fee Related JP4717349B2 (ja) | 2001-11-16 | 2002-11-18 | 細胞の除去又は破壊を必要とする腫瘍及び他の状態の治療に有効なペプチド |
JP2011011764A Expired - Fee Related JP5357196B2 (ja) | 2001-11-16 | 2011-01-24 | 細胞の除去又は破壊を必要とする腫瘍及び他の状態の治療に有効なペプチド |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011011764A Expired - Fee Related JP5357196B2 (ja) | 2001-11-16 | 2011-01-24 | 細胞の除去又は破壊を必要とする腫瘍及び他の状態の治療に有効なペプチド |
Country Status (22)
Country | Link |
---|---|
US (5) | US7317077B2 (ja) |
EP (1) | EP1442058B1 (ja) |
JP (2) | JP4717349B2 (ja) |
KR (4) | KR20140044399A (ja) |
CN (1) | CN100509846C (ja) |
AT (1) | ATE333467T1 (ja) |
AU (1) | AU2002342463B2 (ja) |
BR (1) | BRPI0213786B8 (ja) |
CA (1) | CA2467053C (ja) |
CY (1) | CY1107578T1 (ja) |
DE (1) | DE60213274T2 (ja) |
DK (1) | DK1442058T3 (ja) |
EA (1) | EA007203B1 (ja) |
ES (1) | ES2269775T3 (ja) |
IL (2) | IL161591A0 (ja) |
MX (1) | MXPA04004489A (ja) |
NO (1) | NO332842B1 (ja) |
NZ (1) | NZ532721A (ja) |
PL (1) | PL207591B1 (ja) |
PT (1) | PT1442058E (ja) |
WO (1) | WO2003044053A2 (ja) |
ZA (1) | ZA200403624B (ja) |
Families Citing this family (100)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7317077B2 (en) * | 2001-11-16 | 2008-01-08 | Nymox Pharmaceutical Corporation | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
DE202004021941U1 (de) | 2003-09-12 | 2013-05-13 | Vessix Vascular, Inc. | Auswählbare exzentrische Remodellierung und/oder Ablation von atherosklerotischem Material |
US20090232866A1 (en) * | 2003-10-07 | 2009-09-17 | Mariann Pavone-Gyongyosi | Oligopeptides as coating material for medical products |
US20050226883A1 (en) * | 2004-02-06 | 2005-10-13 | Paul Averback | Humanized antibody |
US8396548B2 (en) | 2008-11-14 | 2013-03-12 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
US9713730B2 (en) | 2004-09-10 | 2017-07-25 | Boston Scientific Scimed, Inc. | Apparatus and method for treatment of in-stent restenosis |
US9277955B2 (en) | 2010-04-09 | 2016-03-08 | Vessix Vascular, Inc. | Power generating and control apparatus for the treatment of tissue |
CN100427502C (zh) * | 2005-06-09 | 2008-10-22 | 南京大学 | 抗肿瘤寡肽及其制备方法和应用 |
MX2008010942A (es) | 2006-02-28 | 2008-09-03 | Nymox Corp | Peptidos efectivos en el tratamiento de tumores y otras condiciones que requieren la remocion o destruccion de celulas. |
EA200801942A1 (ru) * | 2006-03-10 | 2009-02-27 | Наймокс Корпорейшн | Способ предотвращения или уменьшения риска возникновения рака с использованием пептидов на основе белков нервных волокон |
US8019435B2 (en) | 2006-05-02 | 2011-09-13 | Boston Scientific Scimed, Inc. | Control of arterial smooth muscle tone |
US20080027005A1 (en) * | 2006-07-31 | 2008-01-31 | Paul Averback | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
ES2407329T3 (es) | 2006-10-18 | 2013-06-12 | Vessix Vascular, Inc. | Sistema para inducir efectos de temperatura deseables sobre un tejido corporal |
WO2008049082A2 (en) | 2006-10-18 | 2008-04-24 | Minnow Medical, Inc. | Inducing desirable temperature effects on body tissue |
JP5312337B2 (ja) | 2006-10-18 | 2013-10-09 | べシックス・バスキュラー・インコーポレイテッド | 標的組織の選択的な処置のための調節されたrfエネルギーおよび電気的な組織の特徴付け |
JP5307900B2 (ja) | 2008-11-17 | 2013-10-02 | べシックス・バスキュラー・インコーポレイテッド | 組織トポグラフィの知識によらないエネルギーの選択的な蓄積 |
CA2758449C (en) | 2009-04-13 | 2021-11-30 | The Feinstein Institute For Medical Research | Treatment of inflammatory diseases by inhibiting cold-inducible rna-binding protein (cirp) |
US9192790B2 (en) | 2010-04-14 | 2015-11-24 | Boston Scientific Scimed, Inc. | Focused ultrasonic renal denervation |
US8473067B2 (en) | 2010-06-11 | 2013-06-25 | Boston Scientific Scimed, Inc. | Renal denervation and stimulation employing wireless vascular energy transfer arrangement |
US9358365B2 (en) | 2010-07-30 | 2016-06-07 | Boston Scientific Scimed, Inc. | Precision electrode movement control for renal nerve ablation |
US9463062B2 (en) | 2010-07-30 | 2016-10-11 | Boston Scientific Scimed, Inc. | Cooled conductive balloon RF catheter for renal nerve ablation |
US9408661B2 (en) | 2010-07-30 | 2016-08-09 | Patrick A. Haverkost | RF electrodes on multiple flexible wires for renal nerve ablation |
US9155589B2 (en) | 2010-07-30 | 2015-10-13 | Boston Scientific Scimed, Inc. | Sequential activation RF electrode set for renal nerve ablation |
US9084609B2 (en) | 2010-07-30 | 2015-07-21 | Boston Scientific Scime, Inc. | Spiral balloon catheter for renal nerve ablation |
US8974451B2 (en) | 2010-10-25 | 2015-03-10 | Boston Scientific Scimed, Inc. | Renal nerve ablation using conductive fluid jet and RF energy |
US9220558B2 (en) | 2010-10-27 | 2015-12-29 | Boston Scientific Scimed, Inc. | RF renal denervation catheter with multiple independent electrodes |
US9028485B2 (en) | 2010-11-15 | 2015-05-12 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
US9089350B2 (en) | 2010-11-16 | 2015-07-28 | Boston Scientific Scimed, Inc. | Renal denervation catheter with RF electrode and integral contrast dye injection arrangement |
US9668811B2 (en) | 2010-11-16 | 2017-06-06 | Boston Scientific Scimed, Inc. | Minimally invasive access for renal nerve ablation |
US9326751B2 (en) | 2010-11-17 | 2016-05-03 | Boston Scientific Scimed, Inc. | Catheter guidance of external energy for renal denervation |
US9060761B2 (en) | 2010-11-18 | 2015-06-23 | Boston Scientific Scime, Inc. | Catheter-focused magnetic field induced renal nerve ablation |
US9192435B2 (en) | 2010-11-22 | 2015-11-24 | Boston Scientific Scimed, Inc. | Renal denervation catheter with cooled RF electrode |
US9023034B2 (en) | 2010-11-22 | 2015-05-05 | Boston Scientific Scimed, Inc. | Renal ablation electrode with force-activatable conduction apparatus |
US20120157993A1 (en) | 2010-12-15 | 2012-06-21 | Jenson Mark L | Bipolar Off-Wall Electrode Device for Renal Nerve Ablation |
US9220561B2 (en) | 2011-01-19 | 2015-12-29 | Boston Scientific Scimed, Inc. | Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury |
CN103813745B (zh) | 2011-07-20 | 2016-06-29 | 波士顿科学西美德公司 | 用以可视化、对准和消融神经的经皮装置及方法 |
AU2012287189B2 (en) | 2011-07-22 | 2016-10-06 | Boston Scientific Scimed, Inc. | Nerve modulation system with a nerve modulation element positionable in a helical guide |
EP2765942B1 (en) | 2011-10-10 | 2016-02-24 | Boston Scientific Scimed, Inc. | Medical devices including ablation electrodes |
US9420955B2 (en) | 2011-10-11 | 2016-08-23 | Boston Scientific Scimed, Inc. | Intravascular temperature monitoring system and method |
US10085799B2 (en) | 2011-10-11 | 2018-10-02 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
US9364284B2 (en) | 2011-10-12 | 2016-06-14 | Boston Scientific Scimed, Inc. | Method of making an off-wall spacer cage |
EP2768568B1 (en) | 2011-10-18 | 2020-05-06 | Boston Scientific Scimed, Inc. | Integrated crossing balloon catheter |
EP2768563B1 (en) | 2011-10-18 | 2016-11-09 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
CN104023662B (zh) | 2011-11-08 | 2018-02-09 | 波士顿科学西美德公司 | 孔部肾神经消融 |
WO2013074813A1 (en) | 2011-11-15 | 2013-05-23 | Boston Scientific Scimed, Inc. | Device and methods for renal nerve modulation monitoring |
US9119632B2 (en) | 2011-11-21 | 2015-09-01 | Boston Scientific Scimed, Inc. | Deflectable renal nerve ablation catheter |
US9265969B2 (en) | 2011-12-21 | 2016-02-23 | Cardiac Pacemakers, Inc. | Methods for modulating cell function |
EP2793724B1 (en) | 2011-12-23 | 2016-10-12 | Vessix Vascular, Inc. | Apparatuses for remodeling tissue of or adjacent to a body passage |
CN104135958B (zh) | 2011-12-28 | 2017-05-03 | 波士顿科学西美德公司 | 用有聚合物消融元件的新消融导管调变神经的装置和方法 |
US9050106B2 (en) | 2011-12-29 | 2015-06-09 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
WO2013169927A1 (en) | 2012-05-08 | 2013-11-14 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices |
US10321946B2 (en) | 2012-08-24 | 2019-06-18 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices with weeping RF ablation balloons |
CN104780859B (zh) | 2012-09-17 | 2017-07-25 | 波士顿科学西美德公司 | 用于肾神经调节的自定位电极系统及方法 |
US10398464B2 (en) | 2012-09-21 | 2019-09-03 | Boston Scientific Scimed, Inc. | System for nerve modulation and innocuous thermal gradient nerve block |
US10549127B2 (en) | 2012-09-21 | 2020-02-04 | Boston Scientific Scimed, Inc. | Self-cooling ultrasound ablation catheter |
JP6074051B2 (ja) | 2012-10-10 | 2017-02-01 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | 血管内神経変調システム及び医療用デバイス |
WO2014143571A1 (en) | 2013-03-11 | 2014-09-18 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
WO2014163987A1 (en) | 2013-03-11 | 2014-10-09 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9808311B2 (en) | 2013-03-13 | 2017-11-07 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
WO2014149690A2 (en) | 2013-03-15 | 2014-09-25 | Boston Scientific Scimed, Inc. | Medical devices and methods for treatment of hypertension that utilize impedance compensation |
JP6220044B2 (ja) | 2013-03-15 | 2017-10-25 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | 腎神経アブレーションのための医療用デバイス |
US10265122B2 (en) | 2013-03-15 | 2019-04-23 | Boston Scientific Scimed, Inc. | Nerve ablation devices and related methods of use |
JP2016523147A (ja) | 2013-06-21 | 2016-08-08 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | 同乗型電極支持体を備えた腎除神経バルーンカテーテル |
JP2016524949A (ja) | 2013-06-21 | 2016-08-22 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | 回転可能シャフトを有する腎神経アブレーション用医療装置 |
US9707036B2 (en) | 2013-06-25 | 2017-07-18 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation using localized indifferent electrodes |
US9833283B2 (en) | 2013-07-01 | 2017-12-05 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
US10413357B2 (en) | 2013-07-11 | 2019-09-17 | Boston Scientific Scimed, Inc. | Medical device with stretchable electrode assemblies |
US10660698B2 (en) | 2013-07-11 | 2020-05-26 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation |
WO2015010074A1 (en) | 2013-07-19 | 2015-01-22 | Boston Scientific Scimed, Inc. | Spiral bipolar electrode renal denervation balloon |
EP3024406B1 (en) | 2013-07-22 | 2019-06-19 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
JP6122217B2 (ja) | 2013-07-22 | 2017-04-26 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | 腎神経アブレーション用医療器具 |
JP6159888B2 (ja) | 2013-08-22 | 2017-07-05 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | 腎神経変調バルーンへの接着性を向上させたフレキシブル回路 |
US9895194B2 (en) | 2013-09-04 | 2018-02-20 | Boston Scientific Scimed, Inc. | Radio frequency (RF) balloon catheter having flushing and cooling capability |
US10952790B2 (en) | 2013-09-13 | 2021-03-23 | Boston Scientific Scimed, Inc. | Ablation balloon with vapor deposited cover layer |
JP6615100B2 (ja) | 2013-09-24 | 2019-12-04 | ザ ファインスタイン インスティチュート フォー メディカル リサーチ | 低温誘導性rna結合タンパク質活性を阻害するペプチド |
WO2015057521A1 (en) | 2013-10-14 | 2015-04-23 | Boston Scientific Scimed, Inc. | High resolution cardiac mapping electrode array catheter |
US11246654B2 (en) | 2013-10-14 | 2022-02-15 | Boston Scientific Scimed, Inc. | Flexible renal nerve ablation devices and related methods of use and manufacture |
US9770606B2 (en) | 2013-10-15 | 2017-09-26 | Boston Scientific Scimed, Inc. | Ultrasound ablation catheter with cooling infusion and centering basket |
US9962223B2 (en) | 2013-10-15 | 2018-05-08 | Boston Scientific Scimed, Inc. | Medical device balloon |
JP6259099B2 (ja) | 2013-10-18 | 2018-01-10 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | 可撓性を備える導電性ワイヤを備えるバルーン・カテーテル、並びに関連する使用および製造方法 |
JP2016534842A (ja) | 2013-10-25 | 2016-11-10 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | 除神経フレックス回路における埋め込み熱電対 |
JP6382989B2 (ja) | 2014-01-06 | 2018-08-29 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | 耐引き裂き性フレキシブル回路アセンブリを備える医療デバイス |
EP3102136B1 (en) | 2014-02-04 | 2018-06-27 | Boston Scientific Scimed, Inc. | Alternative placement of thermal sensors on bipolar electrode |
US11000679B2 (en) | 2014-02-04 | 2021-05-11 | Boston Scientific Scimed, Inc. | Balloon protection and rewrapping devices and related methods of use |
US20160215031A1 (en) * | 2015-01-27 | 2016-07-28 | Nymox Pharnaceutical Corporation | Method of treating disorders requiring destruction or removal of cells |
US10078207B2 (en) | 2015-03-18 | 2018-09-18 | Endochoice, Inc. | Systems and methods for image magnification using relative movement between an image sensor and a lens assembly |
US20160361380A1 (en) | 2015-06-12 | 2016-12-15 | Nymox Corporation | Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations |
CA3029064A1 (en) * | 2015-06-29 | 2017-01-05 | The University Of British Columbia | Mammalian glucosidase inhibitors, methods for their use and pharmaceutical compositions thereof |
US11628202B2 (en) * | 2015-07-24 | 2023-04-18 | Nymox Corporation | Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia |
US10183058B2 (en) * | 2016-06-17 | 2019-01-22 | Nymox Corporation | Method of preventing or reducing the progression of prostate cancer |
US10172910B2 (en) | 2016-07-28 | 2019-01-08 | Nymox Corporation | Method of preventing or reducing the incidence of acute urinary retention |
US10532081B2 (en) | 2016-09-07 | 2020-01-14 | Nymox Corporation | Method of ameliorating or preventing the worsening or the progression of symptoms of BPH |
US10335453B2 (en) | 2017-03-01 | 2019-07-02 | Nymox Corporation | Compositions and methods for improving sexual function |
US10835538B2 (en) | 2018-03-28 | 2020-11-17 | Nymox Corporation | Method of treating benign prostatic hyperlasia with antibiotics |
US20200061150A1 (en) | 2018-08-23 | 2020-02-27 | Nymox Corporation | Method of inducing selective prostate glandular pharmaco-ablation with sparing of nerves and preservation of sexual function |
US11298400B2 (en) | 2019-05-13 | 2022-04-12 | Nymox Corporation | Method of enhancing the therapeutic efficacy of fexapotide triflutate in treating LUTS |
US20200360466A1 (en) | 2019-05-13 | 2020-11-19 | Nymox Corporation | Method of improving lower urinary tract symptoms |
US11278588B2 (en) | 2019-05-13 | 2022-03-22 | Nymox Corporation | Method of treating lower urinary tract symptoms with fexapotide triflutate |
US11331374B2 (en) | 2019-07-31 | 2022-05-17 | Nymox Corporation | Focal treatment of prostate cancer |
US11231421B2 (en) | 2019-07-31 | 2022-01-25 | Nymox Corporation | Methods of treating multifocal cancer |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US594863A (en) * | 1897-12-07 | Otto p | ||
US5169933A (en) * | 1988-08-15 | 1992-12-08 | Neorx Corporation | Covalently-linked complexes and methods for enhanced cytotoxicity and imaging |
ATE145285T1 (de) * | 1988-12-21 | 1996-11-15 | Gen Hospital Corp | Nachweis einer neurologischen krankheit oder einer funktionsstörung |
US5948634A (en) * | 1988-12-21 | 1999-09-07 | The General Hospital Coporation | Neural thread protein gene expression and detection of alzheimer's disease |
JPH06256387A (ja) | 1991-06-14 | 1994-09-13 | Suetsuna Yoko | 新規なペプチド、その製法およびそれを有効成分とする 血圧降下剤 |
CA2161097A1 (en) | 1993-04-20 | 1994-10-27 | Suzanne M. De La Monte | Neural thread protein gene expression and detection of alzheimer's disease |
FR2757486B1 (fr) | 1996-12-24 | 1999-03-26 | Sanofi Sa | Receptacle de conditionnement de deux produits pouvant s'ecouler et maintenus separes avant d'etre melanges pour utilisation |
AU749348B2 (en) | 1997-02-26 | 2002-06-27 | General Hospital Corporation, The | Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's disease |
US6238667B1 (en) * | 1997-09-19 | 2001-05-29 | Heinz Kohler | Method of affinity cross-linking biologically active immunogenic peptides to antibodies |
JP2002519311A (ja) * | 1998-06-26 | 2002-07-02 | ジョージタウン・ユニバーシティ・メディカル・センター | 細胞死を誘発するための組成物と方法 |
WO2000018426A1 (fr) * | 1998-09-30 | 2000-04-06 | The Institute Of Physical And Chemical Research | Inducteurs d'apoptose |
AU2373800A (en) * | 1998-12-11 | 2000-06-26 | Incyte Pharmaceuticals, Inc. | Neuron-associated proteins |
PT1143994E (pt) * | 1999-01-11 | 2003-11-28 | Leadd Bv | Utilizacao de agentes indutores de apoptose na preparacao de um medicamento para o tratamento de doencas (auto) imunes |
CA2364630A1 (en) | 1999-03-12 | 2000-09-21 | Human Genome Sciences, Inc. | 50 human secreted proteins |
WO2000058339A2 (en) | 1999-03-26 | 2000-10-05 | Human Genome Sciences, Inc. | 50 human secreted proteins |
CA2365223A1 (en) | 1999-03-19 | 2000-09-28 | Craig A. Rosen | 46 human secreted proteins |
CA2368927A1 (en) | 1999-03-26 | 2000-10-05 | Craig A. Rosen | 45 human secreted proteins |
AU6745700A (en) | 1999-03-26 | 2000-11-02 | Human Genome Sciences, Inc. | 49 human secreted proteins |
JP2003514002A (ja) | 1999-11-16 | 2003-04-15 | ユニリーバー・ナームローゼ・ベンノートシヤープ | アニス抽出物とレチノイドを含む美容組成物 |
CA2392948A1 (en) | 1999-11-30 | 2001-06-07 | Curagen Corporation | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
CN1300779A (zh) | 1999-12-22 | 2001-06-27 | 上海博德基因开发有限公司 | 一种新的多肽-人神经元线蛋白17和编码这种多肽的多核苷酸 |
CN1300783A (zh) | 1999-12-23 | 2001-06-27 | 上海生元基因开发有限公司 | 新的人神经元线蛋白及其编码序列 |
AU2001271455A1 (en) | 2000-06-26 | 2002-01-08 | Millennium Pharmaceuticals, Inc. | A human calcium channel protein and uses thereof |
US6783969B1 (en) | 2001-03-05 | 2004-08-31 | Nuvelo, Inc. | Cathepsin V-like polypeptides |
ATE381342T1 (de) * | 2001-05-16 | 2008-01-15 | Nymox Corp | Prävention des zelltodes durch verwendung von segmenten der neurofilamentproteinen |
CN1582301A (zh) * | 2001-05-25 | 2005-02-16 | 尼莫克斯股份有限公司 | 有效治疗肿瘤和其它需要除去或破坏细胞的疾病的肽 |
JP4587667B2 (ja) * | 2001-07-19 | 2010-11-24 | ナイモックス コーポレーション | 細胞の除去又は破壊を必要とする腫瘍及び他の状態の治療に有効なペプチド |
US7317077B2 (en) * | 2001-11-16 | 2008-01-08 | Nymox Pharmaceutical Corporation | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
-
2002
- 2002-11-15 US US10/294,891 patent/US7317077B2/en not_active Expired - Fee Related
- 2002-11-18 AU AU2002342463A patent/AU2002342463B2/en not_active Ceased
- 2002-11-18 EP EP02779063A patent/EP1442058B1/en not_active Expired - Lifetime
- 2002-11-18 JP JP2003545688A patent/JP4717349B2/ja not_active Expired - Fee Related
- 2002-11-18 AT AT02779063T patent/ATE333467T1/de active
- 2002-11-18 ES ES02779063T patent/ES2269775T3/es not_active Expired - Lifetime
- 2002-11-18 KR KR1020147006037A patent/KR20140044399A/ko not_active Application Discontinuation
- 2002-11-18 NZ NZ532721A patent/NZ532721A/en not_active IP Right Cessation
- 2002-11-18 CA CA2467053A patent/CA2467053C/en not_active Expired - Fee Related
- 2002-11-18 KR KR1020107026566A patent/KR101375026B1/ko not_active IP Right Cessation
- 2002-11-18 WO PCT/CA2002/001757 patent/WO2003044053A2/en active Application Filing
- 2002-11-18 EA EA200400632A patent/EA007203B1/ru not_active IP Right Cessation
- 2002-11-18 KR KR1020127024763A patent/KR20120123573A/ko not_active Application Discontinuation
- 2002-11-18 IL IL16159102A patent/IL161591A0/xx unknown
- 2002-11-18 MX MXPA04004489A patent/MXPA04004489A/es active IP Right Grant
- 2002-11-18 DE DE60213274T patent/DE60213274T2/de not_active Expired - Lifetime
- 2002-11-18 BR BRPI0213786A patent/BRPI0213786B8/pt not_active IP Right Cessation
- 2002-11-18 DK DK02779063T patent/DK1442058T3/da active
- 2002-11-18 PT PT02779063T patent/PT1442058E/pt unknown
- 2002-11-18 KR KR1020047007366A patent/KR20050044471A/ko not_active Application Discontinuation
- 2002-11-18 PL PL370891A patent/PL207591B1/pl unknown
- 2002-11-18 CN CNB028228014A patent/CN100509846C/zh not_active Expired - Fee Related
-
2004
- 2004-04-22 IL IL161591A patent/IL161591A/en not_active IP Right Cessation
- 2004-05-04 NO NO20041844A patent/NO332842B1/no not_active IP Right Cessation
- 2004-05-12 ZA ZA2004/03624A patent/ZA200403624B/en unknown
- 2004-10-12 US US10/920,313 patent/US7408021B2/en not_active Expired - Lifetime
-
2006
- 2006-10-17 CY CY20061101487T patent/CY1107578T1/el unknown
-
2008
- 2008-07-11 US US12/171,462 patent/US8293703B2/en not_active Expired - Lifetime
-
2009
- 2009-06-15 US US12/484,696 patent/US7745572B2/en not_active Expired - Lifetime
-
2011
- 2011-01-24 JP JP2011011764A patent/JP5357196B2/ja not_active Expired - Fee Related
-
2012
- 2012-10-11 US US13/649,632 patent/US8569446B2/en not_active Expired - Lifetime
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2005521383A5 (ja) | ||
JP2005506061A5 (ja) | ||
JP2005507647A5 (ja) | ||
JP2004534533A5 (ja) | ||
JP5490343B2 (ja) | Jnkシグナル導入経路の細胞透過性ペプチドインヒビター | |
US7919098B2 (en) | ErbB-3 based methods and compositions for treating neoplasms | |
JP2004529908A5 (ja) | ||
ES2400920T3 (es) | Péptidos eficaces en el tratamiento de tumores y otras afecciones que requieren la eliminación o la destrucción de células | |
CA2371922A1 (en) | Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases | |
JP2004537260A5 (ja) | ||
JP2021509104A (ja) | ヒトフェリチンおよびプロテアーゼ切断可能ペプチドに基づく融合タンパク質ならびに化学療法用担体としてのそれらの使用 | |
EA010435B1 (ru) | Связывающиеся с tall-1 молекулы и их применение | |
CN1295617A (zh) | 血管生成因子-血管内皮细胞生长因子vegf的突变体 | |
JP2009545313A5 (ja) | ||
SK38998A3 (en) | Truncated glial cell line-derived neurotrophic factor | |
JP2004528266A (ja) | 薬物送達用組成物 | |
JP2006517104A (ja) | トランスポゾンに基づく標的化システム | |
Lin et al. | Neuregulin‑1, a microvascular endothelial‑derived protein, protects against myocardial ischemia‑reperfusion injury | |
CA2378925A1 (en) | Matrix-targeted fusion polypeptides for tissue regeneration and wound healing | |
JP2006518203A (ja) | トランスポゾンに基づく標的化システム | |
JP2007511534A5 (ja) | ||
JPWO2003078460A1 (ja) | ペプチド、該ペプチドを含有する医薬組成物及び癌治療用医薬組成物 | |
JPWO2020055812A5 (ja) | ||
ES2285755T3 (es) | Material biologico para el tratamiento de un mamifero por transferencia de genes de anticuerpos y composicion farmaceutica que lo contiene. | |
CN110857315A (zh) | 一种治疗肿瘤的多肽药物、衍生物及其使用方法 |